Skip to main content
. Author manuscript; available in PMC: 2024 May 15.
Published in final edited form as: Bioorg Med Chem Lett. 2023 Apr 23;88:129288. doi: 10.1016/j.bmcl.2023.129288

Figure 3.

Figure 3.

Acitivity-based dose-response curves of V8 against Nek2 kinase [A], and other related mitotic kinases [B], Plk1, Nek7, CDK1, and Aurora A. The points are experimental and the line joining them are the fit to obtain the IC50 values.